Adiponectin in Cardiovascular Biology and Pathology
脂联素在心血管生物学和病理学中的作用
基本信息
- 批准号:7217666
- 负责人:
- 金额:$ 45.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-07-01 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:adipocytesadiponectinatherosclerosisbiological signal transductionblood vesselscadherinscoronary disordercyclic AMPgenetically modified animalsglucose metabolismlaboratory mousemetabolismnitric oxidenuclear factor kappa betaprotein isoformsprotein kinaseprotein structure functionreceptortransfection /expression vectorvascular endotheliumvascular smooth muscle
项目摘要
Our overall goal to understand the role of the adipokine adiponectin in vascular function, atherosclerosis,
and coronary heart disease. Adiponectin is produced exclusively by adipocytes and is found at high levels
in the intima surrounding several types of blood vessels. Adiponectin plays a key role in regulating
hepatic and muscle fat and glucose metabolism and also the metabolism and proliferation of vascular
smooth muscle and possibly endothelial cells. We identified several adiponectin orthologs, expressed
mainly by adipocytes that share biological activities and signaling properties with adiponectin; these, like
adiponectin, may regulate metabolism of vascular cells. The identities of the adiponectin signaling
receptors and signal transduction pathways are not known; our and other labs have unequivocally shown
that previously reported, putative signaling receptors for adiponectin do not function in that capacity. We
identified T-cadherin, a GPI- anchored surface protein, as an adiponectin binding protein that is highly and
specifically expressed by cells in the blood vessel intima. Deletion of T-cadherin in mice results in a
decrease in adiponectin in the vasculature and a major increase in the circulation, indicating it is a major
adiponectin receptor. However, additional cell surface receptors are necessary to mediate adiponectin
signaling. We will clone these signaling adiponectin receptors, analyze their structures and functions in
vitro and in vivo, and determine the signal transduction pathways activated in cultured vascular endothelial
and smooth muscle cells by the three isoforms of adiponectin, focusing initially on the AMP- activated
protein kinase, and NF-kB, MAP kinase, and NO pathways. Cells from T-cadherin -/- mice will allow us to
continue to explore the role of this receptor in adiponectin signaling and localization in the vasculature.
Importantly, with Projects I and II we will determine the effects of the various isoforms and orthologs of
adiponectin and of T-cadherin on blood vessel endothelial and smooth muscle cells and on
atherosclerosis and CHD in apoE -/- and SR-BI/apoE double knockout (dKO) mice. Thus, over the
coming five years we hope to elucidate the roles of adiponectin and its principal vascular binding protein,
T-cadherin, in maintaining the normal state of vascular endothelial and smooth muscle cells, and
understand whether and how deletion of either of these proteins leads to atherosclerosis, thrombosis and
CHD.
我们的总体目标是了解脂肪因子脂联素在血管功能、动脉粥样硬化、
和冠心病。脂联素仅由脂肪细胞产生,并且含量很高
存在于几种血管周围的内膜中。脂联素在调节中起关键作用
肝脏和肌肉的脂肪和葡萄糖代谢以及血管的代谢和增殖
平滑肌和可能的内皮细胞。我们鉴定了几种脂联素直向同源物,表达
主要由与脂联素具有相同生物活性和信号传导特性的脂肪细胞组成;这些,比如
脂联素,可调节血管细胞的代谢。脂联素信号传导的特性
受体和信号转导途径未知;我们和其他实验室已经明确表明
据先前报道,脂联素的假定信号受体不能以这种能力发挥作用。我们
鉴定出 T-钙粘蛋白(一种 GPI 锚定表面蛋白)作为脂联素结合蛋白,具有高度和
由血管内膜细胞特异性表达。小鼠体内 T-钙粘蛋白的缺失会导致
脉管系统中脂联素的减少和循环的显着增加,表明它是一个主要的
脂联素受体。然而,需要额外的细胞表面受体来介导脂联素
发信号。我们将克隆这些信号脂联素受体,分析它们的结构和功能
体外和体内,并确定培养的血管内皮细胞中激活的信号转导途径
和平滑肌细胞由脂联素的三种亚型组成,首先关注 AMP 激活的
蛋白激酶、NF-kB、MAP 激酶和 NO 途径。来自 T-钙粘蛋白 -/- 小鼠的细胞将使我们能够
继续探索该受体在脂联素信号传导和脉管系统定位中的作用。
重要的是,通过项目 I 和 II,我们将确定各种异构体和直系同源物的影响
脂联素和 T-钙粘蛋白对血管内皮细胞和平滑肌细胞的影响
apoE -/- 和 SR-BI/apoE 双敲除 (dKO) 小鼠中的动脉粥样硬化和冠心病。因此,超过
未来五年,我们希望阐明脂联素及其主要血管结合蛋白的作用,
T-钙粘蛋白,维持血管内皮细胞和平滑肌细胞的正常状态,以及
了解这些蛋白质的缺失是否以及如何导致动脉粥样硬化、血栓形成和
冠心病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Harvey F Lodish其他文献
Harvey F Lodish的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Harvey F Lodish', 18)}}的其他基金
New Gene Regulatory Proteins Regulating Erythroid Development
调节红细胞发育的新基因调节蛋白
- 批准号:
8205182 - 财政年份:2011
- 资助金额:
$ 45.73万 - 项目类别:
Epo, Integrins and the Control of Erythrpoiesis
Epo、整合素和红细胞生成的控制
- 批准号:
7458640 - 财政年份:2007
- 资助金额:
$ 45.73万 - 项目类别:
Epo, Integrins and the Control of Erythrpoiesis
Epo、整合素和红细胞生成的控制
- 批准号:
7217632 - 财政年份:2006
- 资助金额:
$ 45.73万 - 项目类别:
Growth factors and engineered stroma for HSC expansion
用于 HSC 扩增的生长因子和工程基质
- 批准号:
6895286 - 财政年份:2004
- 资助金额:
$ 45.73万 - 项目类别:
Growth factors and engineered stroma for hematopoietic stem csll (HSC) expansion
用于造血干 csll (HSC) 扩增的生长因子和工程化基质
- 批准号:
7627338 - 财政年份:2004
- 资助金额:
$ 45.73万 - 项目类别:
Growth factors and engineered stroma for hematopoietic stem csll (HSC) expansion
用于造血干 csll (HSC) 扩增的生长因子和工程化基质
- 批准号:
7847420 - 财政年份:2004
- 资助金额:
$ 45.73万 - 项目类别:
相似国自然基金
脂联素通过上调neuronatin改善动脉粥样硬化及其研究
- 批准号:
- 批准年份:2019
- 资助金额:34 万元
- 项目类别:地区科学基金项目
应用血管内OCT研究内皮祖细胞及脂联素对颈动脉斑块易损性的影响
- 批准号:81901218
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
脂联素N-糖链调控脂肪-血管轴抗冠状动脉粥样硬化的作用及机制研究
- 批准号:81873489
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
硝化应激介导血管外膜脂联素表达调控大气超细颗粒物长期呼吸暴露促进动脉粥样硬化疾病发生发展的分子机制
- 批准号:81773390
- 批准年份:2017
- 资助金额:25.0 万元
- 项目类别:面上项目
脂联素通过促进血管旁脂肪内解耦联蛋白-1对抗肥胖引起的内皮功能紊乱及动脉粥样硬化的功能及机理研究
- 批准号:81670800
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
相似海外基金
Adipokines, Sex Hormones and Cardiac Dysfunction in Postmenopausal Women of the MESA Study – An analysis of Secondary Data
MESA 研究中绝经后妇女的脂肪因子、性激素和心脏功能障碍 — 二手数据分析
- 批准号:
10507719 - 财政年份:2022
- 资助金额:
$ 45.73万 - 项目类别:
Follistatin regulation of energy and lipid metabolism during progression of atherosclerosis
卵泡抑素对动脉粥样硬化进展过程中能量和脂质代谢的调节
- 批准号:
10412836 - 财政年份:2022
- 资助金额:
$ 45.73万 - 项目类别:
Follistatin regulation of energy and lipid metabolism during progression of atherosclerosis
卵泡抑素对动脉粥样硬化进展过程中能量和脂质代谢的调节
- 批准号:
10618987 - 财政年份:2022
- 资助金额:
$ 45.73万 - 项目类别:
Integrative analysis of bulk and single-cell RNA-seq data for cardiometabolic disease
心脏代谢疾病的批量和单细胞 RNA-seq 数据的综合分析
- 批准号:
10448317 - 财政年份:2021
- 资助金额:
$ 45.73万 - 项目类别:
Elucidating the Role of Adipokines in Mediating and Predicting HF Associated with Obesity
阐明脂肪因子在调节和预测肥胖相关心力衰竭中的作用
- 批准号:
9883039 - 财政年份:2019
- 资助金额:
$ 45.73万 - 项目类别: